Biomarker Discovery Outsourcing Services Market Expected to Hit USD 83.93 Billion by 2034, at a CAGR of 19.3%

The global biomarker discovery outsourcing services market was estimated to be valued at USD 14.40 billion in 2024. It is expected to reach USD 83.93 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 19.3% from 2025 to 2034.

Market Introduction
Currently majority of drug firms have not yet acquired the comprehensive range of adequately robust potential and capacity in these areas. They require support from external firms. The demand for services in genomics/proteomics research, biomarker identification, and companion diagnostics has been growing rapidly. This has led to the emergence of a new sector within the global pharmaceutical outsourcing industry.

Contract research organizations (CROs) and other specialized firms provide a range of services to pharmaceutical, biotechnology, and academic institutions. These services focus on identifying and validating biomarkers for various applications, including drug discovery and development, diagnostics, personalized medicine, and prognostics. The adoption for these services is increasing as the industry shifts toward precision medicine, personalized therapies, and the growing need for predictive and prognostic tools in healthcare.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/biomarker-discovery-outsourcing-services-market/request-for-sample

Prominent Companies in the Market
The market is consolidated and excessively competitive for both big and moderate firms in the industry. Some of the prominent players operating in the market include:
• Celerion
• Charles River Laboratories International, Inc.
• Eurofins Scientific
• Evotec
• Fujirebio Holdings Inc.
• GenScript ProBio
• ICON plc
• Laboratory Corporation of America Holdings (Labcorp)
• Parexel International (MA) Corporation
• Proteome Sciences
• Thermo Fisher Scientific Inc.
• WuXi AppTec

Biomarker Discovery Outsourcing Services Market Report Highlights
• By type, surrogate endpoints hold the largest market share. Surrogate endpoints serve as indirect measures representing clinical outcomes, enabling researchers to assess treatment efficacy and safety more efficiently during drug development.

• By therapeutic area, oncology dominates the biomarker discovery outsourcing services market, driven by the increasing prevalence of cancer and the growing adoption of biomarker-driven drug development. The use of biomarkers in early cancer detection, prognosis, and treatment selection enhances the segment's significance in clinical research.

• North America holds the largest market share. This dominance is driven by substantial R&D investments, a strong emphasis on precision medicine, and robust collaborations between pharmaceutical companies and contract research organizations (CROs).

• Asia Pacific is experiencing the highest biomarker discovery outsourcing services market CAGR. This rapid expansion is attributed to increasing pharmaceutical R&D activities, a surge in clinical trial operations, and cost-effective outsourcing solutions available in countries such as China and India.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/biomarker-discovery-outsourcing-services-market/request-for-discount-pricing

Market Dynamics
Growing Cases of Chronic Illnesses: The growing cases of chronic illnesses, such as cancer, have notably increased the demand for biomarker discovery outsourcing services. Biomarkers are important instruments in early disease detection, diagnosis, and monitoring, enabling healthcare providers to apply timely and targeted mediation. For instance, the American Cancer Society estimated that in 2022, approximated 1.9 million cancers were detected in the US, underscoring the growing prevalence of this illness. This drives the biomarker discovery outsourcing services market demand.

Inclination for Personalized Medicines: The move towards personalized medicines, which customizes medical treatment to personal genetic profiles and illness attributes, has elevated the demand for accurate and dependable biomarkers. Biomarkers are crucial in recognizing patient subgroups, forecasting therapeutic reactions, and observing treatment results, thus easing customized healthcare mediations.

Market Segmentation
The biomarker discovery outsourcing services market segmentation is based on type, therapeutic area, discovery phase, end use, and region.

Based on type, the surrogate endpoints segment holds the largest market share due to them serving as an incidental measure showcasing clinical outcomes, allowing researchers to examine treatment productivity.

Based on therapeutic area, the oncology segment holds a larger market share owing to the growing existence of cancer globally, which has boosted the demand for progressive biomarkers.

By Type Outlook (Revenue-USD Billion, 2020-2034)
• Predictive Biomarkers
• Prognostic Biomarkers
• Safety Biomarkers
• Surrogate Endpoints

By Therapeutic Area Outlook (Revenue-USD Billion, 2020-2034)
• Oncology
• Neurology
• Cardiology
• Autoimmune Diseases
• Others

By Discovery Phase Outlook (Revenue-USD Billion, 2020-2034)
• Biomarker Identification
• Biomarker Validation
• Biomarker Profiling
• Biomarker Panel Development
• Biomarker Selection

By End Use Outlook (Revenue-USD Billion, 2020-2034)
• Pharmaceutical Companies
• Biotechnology Companies
• Others

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/biomarker-discovery-outsourcing-services-market
Geographical Analysis

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

More Trending Latest Reports by Polaris Market Research:
Osmometers Market
https://www.polarismarketresearch.com/industry-analysis/osmometers-market

Medical Waste Container Market
https://www.polarismarketresearch.com/industry-analysis/medical-waste-container-market

Hysteroscopes Market
https://www.polarismarketresearch.com/industry-analysis/hysteroscopes-market

Audiology Devices Market
https://www.polarismarketresearch.com/industry-analysis/global-audiology-devices-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.